Euclidean Capital LLC
CIK 1825034 · Holdings on Jun 30, 2024 · First reported Aug 14, 2024
Top ten holdings
Q2 2024- SPY78.43%
- INDA17.00%
- FHTX1.14%
- ORIC0.88%
- ALEC0.75%
- PMVP0.53%
- 90138Q1080.50%
- TNYA0.40%
- RAPT0.25%
- SRZN0.12%
Share classes counted separately100.00%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- SPYWeight increased · +13.07 pp65.36% → 78.43%Shares +172.34K (+17.68%)
- INDAWeight increased · +0.96 pp16.04% → 17.00%Shares 0 (0.00%)
- ORICWeight decreased · -0.86 pp1.74% → 0.88%Shares 0 (0.00%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 11
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | SPYSS SPDR S&P 500 ETF TRUST-USTR UNIT View history and evidence | $624.21M | 78.43% | 1.15M shares | 65.36% → 78.43%+13.07 pp +172.34K (+17.68%) | Added | ↗▾ |
| 02 | INDAISHARES MSCI INDIA ETFMSCI INDIA ETF View history and evidence | $135.27M | 17.00% | 2.43M shares | 16.04% → 17.00%+0.96 pp 0 (0.00%) | Unchanged | ↗▾ |
| 03 | FHTXFOGHORN THERAPEUTICS INC View history and evidence | $9.05M | 1.14% | 1.57M shares | 1.35% → 1.14%-0.21 pp 0 (0.00%) | Unchanged | ↗▾ |
| 04 | ORICORIC PHARMACEUTICALS INC View history and evidence | $7.00M | 0.88% | 989.41K shares | 1.74% → 0.88%-0.86 pp 0 (0.00%) | Unchanged | ↗▾ |
| 05 | ALECALECTOR INC View history and evidence | $5.94M | 0.75% | 1.31M shares | 1.01% → 0.75%-0.26 pp 0 (0.00%) | Unchanged | ↗▾ |
| 06 | PMVPPMV PHARMACEUTICALS INC View history and evidence | $4.26M | 0.53% | 2.63M shares | 0.57% → 0.53%-0.04 pp 0 (0.00%) | Unchanged | ↗▾ |
| 07 | 90138Q10823ANDME HOLDING COCLASS A COM View history and evidence | $4.01M | 0.50% | 10.24M shares | 0.70% → 0.50%-0.20 pp 0 (0.00%) | Unchanged | ↗▾ |
| 08 | TNYATENAYA THERAPEUTICS INC View history and evidence | $3.15M | 0.40% | 1.02M shares | 0.68% → 0.40%-0.28 pp 0 (0.00%) | Unchanged | ↗▾ |
| 09 | RAPTRAPT THERAPEUTICS INC View history and evidence | $2.01M | 0.25% | 657.90K shares | 0.76% → 0.25%-0.51 pp 0 (0.00%) | Unchanged | ↗▾ |
| 10 | SRZNSURROZEN INCCOM NEW View history and evidence | $960.27K | 0.12% | 87.70K shares | 0.18% → 0.12%-0.06 pp 0 (0.00%) | Unchanged | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 2
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| GLD SPDR GOLD SHARES | Non-derivative | -432,271 | -$88.93M | SEC filing ↗ | SEC filing ↗ |
| NGM NGM BIOPHARMACEUTICALS INC | Non-derivative | -992,168 | -$1.58M | SEC filing ↗ | SEC filing ↗ |
2 / 2 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1825034 · Period 2024-06-30
Data loaded 2026-09-23 · First reported 2024-08-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 795847649
}Take these holdings further.
This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 11 of 11 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1825034","quarter":"2024Q2","page_size":100}
get_institutional_manager_history
{"cik":"1825034","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.